Australian research has highlighted a high burden of disease in advanced cutaneous squamous cell carcinoma (cSCC) and significant gaps in access to therapies. A study by Sir Charles Gairdner Hospital Medical Oncologist Dr Piyush Grover and colleagues assessed clinicopathological features, morbidity and mortality of 129 high-risk head and neck cSCC patients treated with surgery, chemo- ...
Cancer immunotherapies are prime candidates for advanced cSCC: Australian study
By Natasha Doyle
25 Nov 2021